UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma

Cancer research (Chicago, Ill.), 2015-04, Vol.75 (8), p.1675-1681

2015

Volltextzugriff (PDF)

Therapy-Related Myeloid Leukemias Are Observed in Patients With Chronic Lymphocytic Leukemia After Treatment With Fludarabine and Chlorambucil: Results of an Intergroup Study, Cancer and Leukemia Group B 9011

Journal of clinical oncology, 2002-09, Vol.20 (18), p.3878-3884

2002

Volltextzugriff (PDF)

Bruton tyrosine kinase (BTK) and its role in B-cell malignancy

International reviews of immunology, 2012-04, Vol.31 (2), p.119-132

2012

Volltextzugriff (PDF)

Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth

Molecular cancer therapeutics, 2016-12, Vol.15 (12), p.2835-2844

2016

Volltextzugriff (PDF)

Impact of Therapy With Chlorambucil, Fludarabine, or Fludarabine Plus Chlorambucil on Infections in Patients With Chronic Lymphocytic Leukemia: Intergroup Study Cancer and Leukemia Group B 9011

Journal of clinical oncology, 2001-08, Vol.19 (16), p.3611-3621

2001

Volltextzugriff (PDF)

C-Terminal Threonine Phosphorylation Activates ERM Proteins to Link the Cell's Cortical Lipid Bilayer to the Cytoskeleton

Biochemical and biophysical research communications, 1998-12, Vol.253 (3), p.561-565

1998

Volltextzugriff (PDF)

Immune responses and long‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia

Cancer, 2017-08, Vol.123 (16), p.3061-3072

2017

Volltextzugriff (PDF)

Egress of CD19+CD5+ cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients

Blood, 2013-10, Vol.122 (14), p.2412-2424

2013

Volltextzugriff (PDF)

Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

The Journal of clinical investigation, 2014-11, Vol.124 (11), p.4867-4876

2014

Volltextzugriff (PDF)

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results

British journal of haematology, 2018-03, Vol.180 (6), p.821-830

2018

Volltextzugriff (PDF)

Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols

Urologic oncology, 2008-11, Vol.26 (6), p.610-615

2008

Volltextzugriff (PDF)

Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia

The New England journal of medicine, 2000-12, Vol.343 (24), p.1750-1757

2000

Volltextzugriff (PDF)

Interferon effects upon fluorouracil metabolism by HL-60 cells

Biochemical and biophysical research communications, 1989-09, Vol.163 (2), p.867-874

1989

Volltextzugriff (PDF)

Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma

Cancer, 2002-01, Vol.94 (1), p.25-36

2002

Volltextzugriff (PDF)

Protein kinase C-theta phosphorylation of moesin in the actin-binding sequence

The Journal of biological chemistry, 1998-03, Vol.273 (13), p.7594-7603

1998

Volltextzugriff (PDF)

A Randomized Placebo-Controlled Trial of Recombinant Human Interleukin-11 in Cancer Patients With Severe Thrombocytopenia Due To Chemotherapy

Blood, 1996-05, Vol.87 (9), p.3607-3614

1996

Volltextzugriff (PDF)

A phase II study of thalidomide in advanced metastatic renal cell carcinoma

Investigational new drugs, 2002-11, Vol.20 (4), p.389-393

2002

Volltextzugriff (PDF)

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study

Cancer chemotherapy and pharmacology, 2002-07, Vol.50 (1), p.37-45

2002

Volltextzugriff (PDF)

Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites

Cancer research (Chicago, Ill.), 1988-09, Vol.48 (17), p.4868-4873

1988

Volltextzugriff (PDF)

The Type B Receptor for Tumor Necrosis Factor-α Mediates DNA Fragmentation in HL-60 and U937 Cells and Differentiation in HL-60 Cells

Blood, 1992-09, Vol.80 (5), p.1339-1346

1992

Volltextzugriff (PDF)

A Literature Analysis of Prognostic Factors for Response and Quality of Response of Patients with Renal Cell Carcinoma to Interleukin-2-Based Therapy

Oncology, 2001-01, Vol.61 (2), p.91-101

2001

Volltextzugriff (PDF)

Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study

Cancer, 2000-08, Vol.89 (3), p.597-603

2000

Volltextzugriff (PDF)

Association of 14-3-3 Proteins with Centrosomes

Blood cells, molecules, & diseases, 1996, Vol.22 (3), p.225-237

1996

Volltextzugriff (PDF)

Stimulation by tumor necrosis factor of HL-60 thymidine salvage pathway metabolism dissociated from proliferation

Journal of cellular physiology, 1988-07, Vol.136 (1), p.95-102

Elias, Laurence

1988

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(125)
Tagungsberichte
(1)

Sprache

Englisch
(123)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(110)
Science & Technology
(109)
Life Sciences & Biomedicine
(100)
Female
(57)
Male
(54)
Biological And Medical Sciences
(51)
Adult
(44)
Medical Sciences
(42)
Middle Aged
(39)
Aged
(37)
Oncology
(32)
Animals
(26)
Hematology
(23)
Pharmacology. Drug Treatments
(22)
Adolescent
(19)
Mice
(17)
Aged, 80 And Over
(15)
Antineoplastic Agents
(15)
Biochemistry & Molecular Biology
(12)
Hematologic And Hematopoietic Diseases
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma

Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma

Therapy-Related Myeloid Leukemias Are Observed in Patients With Chronic Lymphocytic Leukemia After Treatment With Fludarabine and Chlorambucil: Results of an Intergroup Study, Cancer and Leukemia Group B 9011

Bruton tyrosine kinase (BTK) and its role in B-cell malignancy

Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth

Impact of Therapy With Chlorambucil, Fludarabine, or Fludarabine Plus Chlorambucil on Infections in Patients With Chronic Lymphocytic Leukemia: Intergroup Study Cancer and Leukemia Group B 9011

C-Terminal Threonine Phosphorylation Activates ERM Proteins to Link the Cell's Cortical Lipid Bilayer to the Cytoskeleton

Immune responses and long‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia

Egress of CD19+CD5+ cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients

Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results

Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols

Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia

Interferon effects upon fluorouracil metabolism by HL-60 cells

Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma

Protein kinase C-theta phosphorylation of moesin in the actin-binding sequence

A Randomized Placebo-Controlled Trial of Recombinant Human Interleukin-11 in Cancer Patients With Severe Thrombocytopenia Due To Chemotherapy

A phase II study of thalidomide in advanced metastatic renal cell carcinoma

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study

Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites

The Type B Receptor for Tumor Necrosis Factor-α Mediates DNA Fragmentation in HL-60 and U937 Cells and Differentiation in HL-60 Cells

A Literature Analysis of Prognostic Factors for Response and Quality of Response of Patients with Renal Cell Carcinoma to Interleukin-2-Based Therapy

Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study

Association of 14-3-3 Proteins with Centrosomes

Stimulation by tumor necrosis factor of HL-60 thymidine salvage pathway metabolism dissociated from proliferation

Aktive Filter

Suchergebnisse filtern